ArticleUrology2025
Risk of Hypertension After Renal Trauma: An Analysis of a Large Insurance Claims Database.
Article in Urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveTo evaluate the risk of new-onset hypertension (HTN) after renal trauma (rT) using a large insurance claims database.
methodsWe conducted a retrospective analysis of Merative MarketScan records from 2011-2017. Patients with rT were compared to controls with isolated bladder or urethral trauma. Patients were excluded if they had both trauma types, pre-existing HTN, <1 year of pre-trauma enrollment data, or age <18 years. Kaplan-Meier curves and multivariate Cox proportional hazards models assessed HTN risk between groups.
resultsA total of 7882 patients (4703 rT) were included. In total, 35% of patients with rT developed de-novo HTN compared to 21% of controls (P <.001). Multivariate analysis demonstrated that patients who suffered rT were nearly twice as likely to develop de-novo HTN (hazard ration 1.8, P <.001). Patients with rT managed with either angioembolization or nephrectomy were at greatest risk of HTN (hazard ration 3.4 and 2.4, respectively, P values <.005). HTN risk was also associated with older age, female sex, higher Charlson Comorbidity Index, longer stay, diabetes, obesity, hyperlipidemia, and alcohol use.
conclusionPatients who suffer rT are at increased risk of developing de-novo HTN. Patients who undergo nephrectomy or angioembolization appear to be at the greatest risk compared to controls. Following rT, patients should be counseled on the risk of new HTN and receive close monitoring of their blood pressure over time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.